Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

At close: February 27 at 2:48:59 PM GMT+1 Select to analyze similar companies using key performance metrics; select up to 4 stocks.

The Soft Tissue Sarcoma market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Soft Tissue ...

Verrica Pharma doses last patient in Part 2 of Phase 2 study for basal cell carcinoma Clinical-stage immuno-oncology company, Lytix Biopharma’s licensing partner Verrica Pharmaceutical Inc has ...

Over the last year, Lytix Biopharma As share price has been traded in a range of 9.96, hitting a high of 15.00, and a low of 5.04. It is classified as being part of the Biotechnology subsector.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...